So what happens when your product fails?

Do you recall it, improve it, dump it or can you profit from it?

Based on the news of the USD 16.6 billion merger by Reckitt Benckiser Group Plc to buy Mead Johnson, we can assume it is the latter. Profit from it.

News of the merger can be found here ( Of course both companies own a multitude of brands and products, but what stands out and makes this interesting is that Reckitt Benckiser owns the Durex brand and Mead Johnson is known for infant formula.

Now if their Durex products fail, they still have the market covered with the infant by hedging their bets and being extra safe, that is how they can fork out USD 16.6 billion.

No harm in being extra safe, people.